Stay updated on Tezepelumab in Atopic Dermatitis Clinical Trial

Sign up to get notified when there's something new on the Tezepelumab in Atopic Dermatitis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tezepelumab in Atopic Dermatitis Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    Change Detected
    Summary
    The value of Revision has been updated from v2.8.0 to v2.8.1, indicating a recent revision in the content of the webpage.
    Difference
    0.1%
    Check dated 2024-06-13T21:11:48.000Z thumbnail image
  3. Check
    2 days ago
    No Change Detected
  4. Check
    3 days ago
    No Change Detected
  5. Check
    4 days ago
    No Change Detected
  6. Check
    9 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 7 to 8, indicating that Tezepelumab as a monotherapy in atopic dermatitis did not reach the targeted efficacy level pre-established for this patient population.
    Difference
    0.1%
    Check dated 2024-06-06T14:18:18.000Z thumbnail image
  7. Check
    23 days ago
    Change Detected
    Summary
    The webpage has been updated to include detailed participation criteria for the study, specifying the eligibility requirements for subjects, such as age range, health conditions, and prior treatments. This replaces the previous update information with a comprehensive description of inclusion and exclusion criteria for potential participants.
    Difference
    43%
    Check dated 2024-05-22T19:33:17.000Z thumbnail image
  8. Check
    44 days ago
    Change Detected
    Summary
    The value 'Go to the classic website' has been updated to 'Site Map'. This change likely indicates a shift in the type of intervention or content being featured on the webpage, possibly related to medical and healthcare publications and documentation.
    Difference
    0.6%
    Check dated 2024-05-01T17:38:48.000Z thumbnail image

Stay in the know with updates to Tezepelumab in Atopic Dermatitis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tezepelumab in Atopic Dermatitis Clinical Trial page.